Boğaziçi CT3
Boğaziçi CT³ Central Laboratory Capabilities
Boğaziçi CT Joint Event #9
About the talk: "Nanoparticle-biomolecule interactions: The next horizon for antibiotics"
Innovative Initiatives in the Health Industry Cluster
At the event organized in collaboration with the ISO 31st Professional Committee for the Pharmaceutical, Medical Device and Equipment Industry and İSEK, discussions focused on innovation and entrepreneurship in the health sector, public support mechanisms, commercialization, and opportunities for inter-institutional collaboration.
Boğaziçi CT³ Open Events #7
As part of the Boğaziçi CT³ Open Events series, this seminar explored current approaches in personalized drug development and perspectives on global collaboration.
“From Molecule to Drug” Research Summer School ’26
Hosted by Boğaziçi University and CT³, the “From Molecule to Drug” Research Summer School 2026 was held on 6–10 July 2026 to promote an interdisciplinary approach to drug research.
We are growing our team at Boğaziçi CT³
Boğaziçi CT³ is growing its team and looking for new colleagues across research, technology transfer, scientific projects, medical device development, imaging, and science communication.
We’re wrapping up TEKNOFEST 2026 with an award!
At ISIF’26, Boğaziçi CT³ showcased six registered inventions and received a Bronze Medal for its “ImmuneFixed Tumor-Cell Preparation System.”
Boğaziçi CT³ is at TASSA 2026!
At TASSA 2026, Boğaziçi CT³ showcased its research infrastructure and opportunities for collaboration, research, and careers in health technologies to the international scientific community.
Boğaziçi CT³ and Boğaziçi TTO are at TEKNOFEST!
At ISIF’26 as part of TEKNOFEST, Boğaziçi CT³ and Boğaziçi TTO showcased innovative technologies and patented inventions, highlighting the journey from research to commercialization.